2m 2m 2m 2m 2m 2m 2m
ADDEX THERAP SP ADS (ADXN)
NASDAQ
$6.91+$0.51 (+7.97%)
Price as of Jun 03, 2026 4:04 PM EDT- $8.4MMarket Cap
- -20.79%1-Year Change
- BiotechnologyIndustry
ADDEX THERAP SP ADS (ADXN)
$6.91+$0.51 (+7.97%)
ADXN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.40 | ||
Change | -$0.25 (-3.76%) | ||
Open | $6.63 | ||
High | $6.63 | ||
Low | $6.40 | ||
Previous Close | $6.65 | ||
Volume | 966 | ||
30-Day Average Volume | 3,123 | ||
1-Week Change | -5.19% | ||
1-Month Change | -8.57% | ||
1-Year Change | -20.79% | ||
3-Year Change | -54.28% | ||
5-Year Change | -96.80% | ||
Fundamentals | |||
Shares Outstanding | 1.3M | ||
Total Assets | $6.4M | ||
Market Cap | $8.4M | ||
Enterprise Value | $6.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/23/2023 | ||
Earnings & Revenue